LCAT and metabolic syndrome: The influence of this SNP identified at position 97 of the mutant LCAT on plasma HDL cholesterol concentration is evidenced by the findings that hypoalphalipoproteinemia is one of the highest prevalent form of dyslipidemia present in this study.